July 30, 2021 -- Bio-Rad Laboratories announced sales increases in its second-quarter financial results for 2021 (end-June 30).
The company said that life science segment net sales for the quarter were $334.2 million, an increase of 32.6% compared to the same quarter in 2020. Clinical diagnostics segment sales meanwhile were $380.2 million, an increase of 34.3% compared to the same period last year.
Overall net sales for the quarter were $715.9 million, an increase of 33.4% compared to $536.9 million reported for the second quarter of 2020.
Company leaders said the performance for both areas was ahead of expectations.